Minister defends bill requiring consultation on injection site applications

The federal government would be irresponsible if it did not insist that recently tabled legislation regarding drug injection sites include provisions requiring community consultation, says a Conservative cabinet minister.

“This is clearly a matter of public health and public safety, and I think Canadians would expect the minister of health to listen carefully to the municipal and community leaders in a jurisdiction where an injection house is proposed,” Pierre Poilievre, the Minister of Employment and Social Development, said in an interview Wednesday.

“I think we need to take into account everybody’s point of view … (and) it would be irresponsible to ignore the voices of the mayor, the police chief and the local community if an application for a drug injection house comes forward.”

In Ottawa, both Mayor Jim Watson and Police Chief Charles Bourdeleau have voiced concerns about setting up an injection site.

The minister’s comments follow criticism this week by safe-injection site proponents who say Bill C-2 makes it harder than ever to establish such sites in Canadian cities.

“Should Bill C-2 become law, it will be extremely difficult to open a supervised injection site anywhere in Canada, including in Ottawa,” said Lisa Wright, an organizer with the Campaign for Safer Consumption Sites, which has been campaigning for such a site in Ottawa.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below